Airway management

FCV® Technology | Control of the patient expiration

Ventinova Medical introduces Evone®, the first and only mechanical ventilator to offer full ventilatory cycle control. Evone® FCV® technology creates a stable gas flow during inspiration followed by a unique active gas flow control during expiration.


Lung pathology

Controlling the expiration flow

FCV® uses relatively low flow rates that range typically between 8 and 16 L/min to adequately ventilate a patient. At these lower flows, gas is better able to reach the lung units that have higher resistance and the dependent lung parts, that have a better perfusion. By controlling the expiration flow, FCV® maintains airway pressure and keeps the gas longer in the alveoli. Thus, FCV® can avoid or delay airway and alveolar collapse, and thereby avoid atelectasis while improving gas exchange. Together, FCV® results in a higher efficient ventilation as compared to conventional ventilation techniques.

Keeping the lung open; a key strategy to prevent postoperative pulmonary complications

Benefits of Higher Efficiency


Abdominal / general anesthetics

Less energy dissipation in the lungs, less impact.

FCV® results in smooth tidal movements of the diaphragm and thoracic wall. This is in contrast to conventional ventilation techniques where, especially during the passive expiratory phase, large instant intratracheal pressure drops are observed due to the collapsing thoracic wall. FCV® results in reduced application of mechanical power and less energy dissipation in the lungs.

Read More


Ablation biopsies



Cardio thoracic anesthesia


Head & Neck anesthesia